CN1981834A - Ointment for treating wound - Google Patents
Ointment for treating wound Download PDFInfo
- Publication number
- CN1981834A CN1981834A CNA2005101115427A CN200510111542A CN1981834A CN 1981834 A CN1981834 A CN 1981834A CN A2005101115427 A CNA2005101115427 A CN A2005101115427A CN 200510111542 A CN200510111542 A CN 200510111542A CN 1981834 A CN1981834 A CN 1981834A
- Authority
- CN
- China
- Prior art keywords
- grams
- ointment
- wound
- vaseline
- healing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
An ointment for treating the wound difficult to heal, especially the chronic ulcer, bed sore and deep wound, is prepared from coptis root, phellodendron bark, myrrh, boric acid, and honey through proportional mixing and stirring.
Description
Technical field
Treatment is difficult to the ointment of healing of wound, relates to the medicine of a kind of treatment and healing of wound, is particularly useful for the healing of chronic ulcer, decubital ulcer and deep wounds.
Technical background
Damaged in common at ordinary times chronic ulcer, decubital ulcer, the degree of depth at II °～III ° small-area burn, cutaneous necrosis, and wound reaches subcutaneous fat, muscle deeply, even wound reaches the tendon place, usually such wound is difficult for growth granulation, epithelial tissue, therefore, much all become cureless wound, given patient's life and spirit is made troubles and painful, endangered patient's body health.Wound for the difficult healing of this class, in clinical treatment, usually adopt traditional Chinese medicine, antibiotics and import dressing such as " pacifying general subsides ", " ulcer subsides " to handle,, also can cure some wounds though can solve some problems, but also there is certain defective, do not reach the requirement of clinical treatment work, as: Chinese medicine " HONGYOU GAO " " eight wet cream " etc. all contains heavy metal " Dong Dan ", and it has toxic and side effects, harmful, and easy contaminated environment.And simple use " HONGYOU GAO ", relatively poor to the antiinflammation of wound, share with other drug or with antibiotics, very inconvenient during use, to the wound of the degree of depth also can cause eczema and easily produce irritated, and the granulation poor growth in the wound." pacify general subsides ", import dressing such as " ulcer subsides " in treatment clinical course, wound is had the good moisture preserving effect, can promote epithelial growth.But, to the wound of inflammation is arranged, do not have the effect of antiinflammatory, and, influence the healing of wound almost the do not grow effect of granulation of the wound of deep layer, relatively poor to the effect of the growth of deep layer wound granulation, and price is more expensive.
Goal of the invention
In order to remedy the deficiency of said medicine and dressing; the inventor is through research and the clinical practice of three more than ten years; propose a kind ofly can have antiinflammatory, promote the growth of granulation protective epithelium to chronic ulcer, decubital ulcer, deep wounds; easy to use; harmless, treatment free from environmental pollution is difficult to the ointment of healing of wound.
The present invention mainly be according to the healing rule of chronic ulcer, decubital ulcer, deep wounds promptly the process of " antiinflammatory, granulation promoting, protection, convergence " select medicament categories and prepare.Ointment of the present invention adopts Rhizoma Coptidis, Cortex Phellodendri, Myrrha, boric acid, Mel and vaseline formulated, wherein:
Rhizoma Coptidis: to golden Portugal bacterium, molten courageous and upright streptococcus, anthrax, the tulase various bacteria has stronger inhibitory action, is good antibiotic medicine.
Cortex Phellodendri: with Rhizoma Coptidis identical effect being arranged, is good external application antibiotic medicine.
Myrrha: have diffusing blood and remove silt, pain relieving, promoting muscle growth functions.
Boric acid: have antiinflammatory, anticorrosion, astringent effect.
Mel:, have the effect of detoxifcation, nutrition, protection wound owing to contain compositions such as glucose, oxide, various vitamin, protein, aminoacid, invertase.
Vaseline: as the basic material of ointment of the present invention.
The component of ointment of the present invention is: add Rhizoma Coptidis 3 grams～7 grams in 100 gram vaseline, Cortex Phellodendri 5 grams～12 grams, Myrrha 4 grams～8 grams, boric acid 3 grams～8 grams, Mel 6 grams～15 grams.
The preparation of ointment of the present invention: at first vaseline is melted under 75 ℃～80 ℃ temperature, the Rhizoma Coptidis of sieving, Cortex Phellodendri through 120 orders, do not have in the vaseline of powdered medicine input fusing and fully mix, add Mel more therein then, boric acid fully mixes, and makes ointment after being stirred to cooling.
The characteristics of ointment of the present invention are: do not contain the treatment raw material to the human body toxic side effect in the ointment; be to human body, environmentally friendly environment-friendly type medicine; effect with good antiinflammatory, granulation promoting, the growth of protection granulation and epithelial tissue growth; and preparation and easy to use; low price not only has good medical effect but also has good social benefit.
The specific embodiment
Embodiment 1
At first 100 gram vaseline are melted under 75 ℃ of temperature, fully mixing in the vaseline of the 3 gram Rhizoma Coptidis of sieving, Cortex Phellodendri 12 grams, Myrrha 4 gram powder input fusings through 120 orders, and then add boric acid 3 gram therein, Mel 6 grams fully mix, and be stirred well to cooling, make ointment.
Embodiment 2
100 gram vaseline are melted under 80 ℃ of temperature, fully mixing in the vaseline of Rhizoma Coptidis 7 grams that sieve through 120 orders, Cortex Phellodendri 5 grams, Myrrha 8 gram powder input fusings, and then add boric acid 8 gram therein, Mel 15 grams fully mix, and are stirred well to cooling, make ointment.
Adopt the clinical case introduction of ointment of the present invention:
| The case kind | Case load | Patient age | Therapeutic effect |
| Chronic ulcer of lower extremity | 16 | 60～86 years old | 9 example healings (wherein 2 routine diabetes) |
| 4 examples take a turn for the better | |||
| 1 example irritated (slight local skin allergy) | |||
| 2 examples are in healing | |||
| Wound causes ulcer (comprising burn) | 16 | 3～100 years old | 15 example healings (wherein routine diabetes), 1 example takes a turn for the better |
| Decubital ulcer | 14 | 55～94 years old | 11 example healings |
| 3 examples are in healing | |||
| Chemotherapy | 2 | 2 example healings | |
| Radiotherapy | 2 | 1 example healing | |
| 1 example takes a turn for the better | |||
| Acute incised wound (contrast) | 1 | 64 years old | With HONGYOU GAO, the general subsides contrast of peace, with ointment of the present invention healing in 6 days in advance. |
Add up to case 51 examples, effective percentage is more than 98%.
Claims (2)
1. treatment is difficult to the ointment of healing of wound, it is characterized in that: in 100 gram vaseline, add Rhizoma Coptidis 3 grams～7 grams, and Cortex Phellodendri 5 grams～12 grams, Myrrha 4 grams～8 grams, boric acid 3 grams～8 grams, Mel 6 grams～15 restrain.
2. treatment is difficult to the ointment of healing of wound, it is characterized in that: at first vaseline is melted under 75 ℃～80 ℃ temperature when ointment prepares, the Rhizoma Coptidis of sieving, Cortex Phellodendri through 120 orders, do not have in the vaseline of powdered medicine input fusing and fully mix, and then add boric acid more therein, Mel fully mixes, and makes ointment after being stirred to cooling always.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101115427A CN100542563C (en) | 2005-12-15 | 2005-12-15 | Treatment is difficult to the ointment of healing of wound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005101115427A CN100542563C (en) | 2005-12-15 | 2005-12-15 | Treatment is difficult to the ointment of healing of wound |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1981834A true CN1981834A (en) | 2007-06-20 |
| CN100542563C CN100542563C (en) | 2009-09-23 |
Family
ID=38164865
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005101115427A Active CN100542563C (en) | 2005-12-15 | 2005-12-15 | Treatment is difficult to the ointment of healing of wound |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100542563C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111514214A (en) * | 2020-04-29 | 2020-08-11 | 南京新康力医药科技有限公司 | Traditional Chinese medicine composition and application |
-
2005
- 2005-12-15 CN CNB2005101115427A patent/CN100542563C/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111514214A (en) * | 2020-04-29 | 2020-08-11 | 南京新康力医药科技有限公司 | Traditional Chinese medicine composition and application |
| CN111514214B (en) * | 2020-04-29 | 2022-03-29 | 南京新康力医药科技有限公司 | Traditional Chinese medicine composition and application |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100542563C (en) | 2009-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20070098671A1 (en) | Composition and method of treatment for irritated skin | |
| Pieper | Honey-based dressings and wound care: an option for care in the United States | |
| CN100379465C (en) | Inflammation-eliminating, pain-stopping, bacteria-resisting, pain-relieving soluble hemostatic gauze and its processing method | |
| CN103933363A (en) | Wound healing paste and preparation method thereof | |
| CN101306163A (en) | Zhixue shengji powder | |
| CN100542563C (en) | Treatment is difficult to the ointment of healing of wound | |
| Thomas et al. | Clinical evaluation of honey-based products for lower extremity wounds in a home care setting | |
| US10232004B2 (en) | Pharmaceutical composition based on Centella asiatica (Hydrocotyle asiatica L.) for the treatment of lower limb ulcers | |
| CN100556425C (en) | A kind of Chinese medicine unguentum of analgetic, hemostatic repercussive and sore-arresting functions | |
| CN101361938A (en) | Kibe paste containing natural zingiber oil | |
| CN106236835A (en) | A kind of plants essential oil spray and its preparation method and application | |
| CN100509032C (en) | Chinese medicinal preparation for treating nasosinusitis and preparation method thereof | |
| CN1903214B (en) | Ointment containing red precipitate | |
| CN101366922B (en) | Proprietary Chinese medicine for treating empyrosis | |
| CN1240408C (en) | Ointment for treating chilblain | |
| CN110433242A (en) | Bedsore powder and preparation method thereof | |
| WO2024042374A1 (en) | Sticking plaster for treatment of finger infections such as paronychia | |
| CN101513458B (en) | Traditional Chinese medicine composition for treatment of scald and preparation method thereof | |
| CN105106475A (en) | Traditional Chinese medicine gel used for treating toxin-accumulating rotting and ulcerating type bedsores during clinical nursing | |
| CN1247204C (en) | Medicine for treating beri-beri | |
| CN100536866C (en) | Western and Chinese medicine integrated ointment for treating ulcer surface of wound on skin | |
| CN101306111A (en) | Medicaments for treating animal trauma | |
| Sakhavar et al. | Comparative study of therapeutic effects of honey and povidone iodine in surgical wound healing in rabbit | |
| CN104161808B (en) | It is a kind of to treat burn, the preparation method of the composition of scald medicament and its drug | |
| CN108420829A (en) | A kind of pet detumescence and promoting granulation cream |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |